Oğuz KARAHAN, Nurkay KATRANCIOĞLU, Öztürk ÖZDEMİR, Öcal BERKAN, Şinasi MANDUZ, Mehmet Birhan YILMAZ

Associations between common 3435 C>T variants of the multi-drug resistance [MDR-1 (ABCB1)] gene and abdominal aortic aneurysm: A pilot study

Amaç: Bu çalışmada, inflamatuvar süreç ve oksidatif strese karşı rol oynadığı ileri sürülen C3435T multi drug rezistans-1 (MDR-1) gen polimorfizminin AAA'daki etkisi ortaya konuldu. Çalışma planı: Bu çalışmada servisimizde AAA tanısı konulduktan sonra ameliyat edilen 58 hasta (41 erkek, 17 kadın; ort. yaş 62.9±6.6) ile abdominal bilgisayarlı tomografi taramasında aort çapları normal olarak ölçülen 58 sağlıklı kişinin (38 erkek, 20 kadın; ort. yaş 58.8±11.6 yıl) periferik kan örneklerinde MDR gen mutasyonu tarandı.Bulgular: MDR-1 C3435T geni CT varyant (x2=5,80, p=0.016) ve MDR-1 C3435T geni TT varyant (x2=11.47 p=0.001) polimorfizmleri AAA'lı hastalarda istatistiksel olarak anlamlı bulundu (p

Multi-drug resistance [MDR-1 (ABCB1)] 3435 geni C>T varyantı ve abdominal aort anevrizması arasındaki ilişki: Pilot çalışma10.5606/tgkdc.dergisi.2011.008

Background: The aim of the study was to reveal the effect of the C3435T MDR-1 gene polymorphism in AAA, which has been postulated to play a role in the inflammatory process and protection against oxidative stress. Methods: In this study, we scanned the MDR gene polymorphisms in peripheral blood samples of the 58 patients (41 males, 17 females; mean age 62.9±6.6 years) whom were operated on after the diagnosis of AAA, and of the 58 healthy individuals (38 males, 20 females; mean age 58.8±11.6 years) have normally measured aorta diameters on abdominal computed tomography scan.Results: We found that MDR-1 C3435T gene CT variant (x2= 5.80; p=0.016) and MDR-1 C3435T gene TT variant (x2=11.47; p=0.001) polymorphisms was statistically significant in AAA cases (p

PDF

___

1) Giusti B, Saracini C, Bolli P, Magi A, Sestini I, Sticchi E, et al. Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm. J Med Genet 2008;45:721-30.
2) White JV, Haas K, Phillips S, Comerota AJ. Adventitial elastolysis is a primary event in aneurysm formation. J Vasc Surg 1993;17:371-80.
3) Annambhotla S, Bourgeois S, Wang X, Lin PH, Yao Q, Chen C. Recent advances in molecular mechanisms of abdominal aortic aneurysm formation. World J Surg 2008;32:976-86.
4) Ernst CB. Abdominal aortic aneurysm.N Engl J Med 1993; 328:1167-72.
5) Urbonavicius S, Urbonaviciene G, Honoré B, Henneberg EW, Vorum H, Lindholt JS. Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture-a systematic review.Eur J Vasc Endovasc Surg 2008;36:273-80.
6) Subramanian K, Woodburn KR, Travis SJ, Hancock J. Secondary interventions following endovascular repair of abdominal aortic aneurysm. Diagn Interv Radiol 2006;12:99-104.
7) Clifton MA. Familial abdominal aortic aneurysms. Br J Surg 1977;64:765-6.
8) Gürbüz A, Özsöyler İ, Yılık L, Güneş T, Aksun M, Uluç E. Combined surgical and endovascular repair of thoracic and thoracoabdominal aortic aneurysms. Turkish J Thorac Cardiovasc Surg 2008;16:146-9.
9) Sezak M. Ewing Prognostic importance of P-glicoprotein expression in Ewing sarcoma. Ege Journal of Medicine 2008;47:7-13.
10) Batetta B, Dessì S, Putzolu M, Sanna F, Spano O, Mulas MF, et al. MDR1 gene expression in normal and atherosclerotic human arteries(1). J Vasc Res 1999;36:261-71.
11) Dombrowski SM, Desai SY, Marroni M, Cucullo L, Goodrich K, Bingaman W, et al. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 2001;42:1501-6.
12) Bebek N, Çine N, Öner GÖ, Eşkazan E, Özbek U. Genotype and Allele frequencies of MDR-1 C3435T polymorphism in Turkish population. Journal of Neurological Sciences 2005; 22:37;261-6.
13) Demirag MK, Bahçivan M, Menekşe S, Saraç A, Kolbakir F, Keçeligil HT. İnfrarenal abdominal aort anevrizmaları ve cerrahi tedavisi. Damar Cerrahisi Dergisi 2005;14:29-34.
14) Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006;26:987-94.
15) Arbatli H, Yağan N, Demirsoy E, Unal M, Tekin S, Numan F, et al. Endovascular treatment of abdominal aortic aneurysms. [Article in Turkish] Anadolu Kardiyol Derg 2003;3:115-21.
16) Sapmaz A, Ozen Karatayli SC, Dağli U, Kiliç ZM, Törüner M, Celik Y, et al. Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease. Turk J Gastroenterol 2008; 19:168-73.
17) Izzotti A, Cartiglia C, Longobardi M, Balansky RM, D’Agostini F, Lubet RA, et al. Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke. FASEB J 2004;18:1559-61.
18) Papp E, Gadawski I, Côté HC. Longitudinal effects of thymidine analogues on mtDNA, mtRNA and multidrug resistance (MDR-1) induction in cultured cells. J Antimicrob Chemother 2008;61:1048-52.
19) Israeli D, Ziaei S, Gonin P, Garcia L. A proposal for the physiological significance of mdr1 and Bcrp1/Abcg2 gene expression in normal tissue regeneration and after cancer therapy. J Theor Biol 2005;232:41-5.
20) Shteinberg D, Halak M, Shapiro S, Kinarty A, Sobol E, Lahat N, et al. Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response. Eur J Vasc Endovasc Surg 2000;20:462-5.
21) Drach J, Gsur A, Hamilton G, Zhao S, Angerler J, Fiegl M, et al. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 1996;88:1747-54.
22) Piquette-Miller M, Pak A, Kim H, Anari R, Shahzamani A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm Res 1998;15:706-11.
23) Li QQ, Wang WJ, Xu JD, Cao XX, Chen Q, Yang JM, et al. Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells. Cancer Sci 2007;98:1767-74.
24) Rizas KD, Ippagunta N, Tilson MD 3rd. Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm. Cardiol Rev 2009;17:201-10.